Jove
Visualize
Contact Us

Related Experiment Videos

SR proteins as potential targets for therapy.

Johann Soret1, Mathieu Gabut, Jamal Tazi

  • 1Institut de Génétique Moléculaire de Montpellier, UMR 5535, IFR 122, Centre National de Recherche Scientifique, 1919, route de Mende, 34293 Montpellier, France.

Progress in Molecular and Subcellular Biology
|November 2, 2006
PubMed
Summary

Serine- and arginine-rich (SR) proteins regulate alternative splicing. Modulating SR protein activity offers promising therapeutic strategies for diseases caused by aberrant splicing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From HIV to Inflammation: How RNA Biology Redefined Drug Discovery.

Drug discovery today·2025
Same author

Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. <i>Cancers</i> 2023, <i>15</i>, 5038.

Cancers·2025
Same author

CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3.

Cancers·2023
Same author

The RasGAP-associated endoribonuclease G3BP mediates stress granule assembly.

The Journal of cell biology·2023
Same author

Retract and Replace: The RasGAP-associated endoribonuclease G3BP assembles stress granules.

The Journal of cell biology·2023
Same author

Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2'O-methylation of ribosomal RNA.

Neuro-oncology·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Serine- and arginine-rich (SR) proteins are crucial for pre-mRNA alternative splicing.
  • Splice site selection relies on regulatory elements like enhancers and silencers.
  • Mutations in these elements can lead to disease-associated aberrant splicing.

Purpose of the Study:

  • To review methods for modulating SR protein activity.
  • To identify promising therapeutic strategies targeting SR splicing factors.

Main Methods:

  • Review of existing literature on SR protein function and modulation.
  • Analysis of therapeutic approaches for aberrant splicing.

Main Results:

  • SR proteins bind to splicing enhancers/silencers to control splice site recognition.

Related Experiment Videos

  • Aberrant splicing, driven by mutations, causes various human diseases.
  • Several strategies exist to correct aberrant splicing by targeting mutations or regulators.

    • Conclusions:

    • Modulating SR splicing factor activity holds significant therapeutic potential.
    • Targeting SR proteins offers a promising avenue for treating splicing-related disorders.